Content developed independently by our editors and supported by our partners. Carrington Garvin had been living the fun-packed life of a typical 21-year-old in Las Vegas—dating, working for a gaming ...
In this video, Nancy S. Reau, MD, FAASLD, AGAF, discusses long-term data from the ELATIVE open-label extension trial of Iqirvo in patients with primary biliary cholangitis.Results presented at The ...
Acute cholangitis is diagnosed on the basis of the clinical features, supported by laboratory evidence of systemic infection. Imaging is helpful in revealing biliary obstruction and any underlying ...
PARIS — Statins can significantly reduce the risk for complications and death from primary sclerosing cholangitis, results from a Swedish registry study show. Primary sclerosing cholangitis is ...
Primary biliary cholangitis (PBC) is a chronic progressive autoimmune disorder characterized by small non-purulent intrahepatic bile duct destruction (ductopenia) and cholestasis. While the etiology ...
Many people with primary biliary cholangitis are not receiving recommended alkaline phosphatase monitoring. Learn more about ...
Primary sclerosing cholangitis is a chronic cholestatic liver and biliary tract disease that can shorten life and may require liver transplantation, according to study data. The prevalence in the ...
| DataM Intelligence AUSTIN, Texas and TOKYO, Nov. 18, 2025 /PRNewswire/ -- According to DataM Intelligence, the Primary Biliary Cholangitis (PBC) Treatment Market reached USD 1.33 billion in 2024 and ...
News-Medical.Net on MSN
Blood group A linked to a higher risk of primary biliary cholangitis
Findings indicate blood group A elevates the risk of primary biliary cholangitis, suggesting ABO group analysis could aid in ...
Elafibranor (Iqirvo) was well tolerated and led to sustained improvements in liver enzyme levels and itch severity through 28 weeks in patients with primary sclerosing cholangitis (PSC), according to ...
—New Patents Covering Use of Nebokitug for the Treatment of Liver Diseases including Primary Sclerosing Cholangitis Issued in China and Russia Providing Coverage Up To 2041— —Further Expands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback